Pdt Partners, LLC Biotechnology

Pdt Partners, LLC

$1.02 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
INCY Incyte Corp	$16.7B	$312,000 0.03% of portfolio	4,734	Q3 2024 Reduced 42.73%
NTLA Intellia Therapeutics, Inc.	$799M	$304,000 0.03% of portfolio	14,814	Q3 2024 Reduced 93.48%
QURE Uni Qure N.V.	$754M	$281,000 0.03% of portfolio	57,199	Q3 2024 Reduced 58.85%
KALV Kal Vista Pharmaceuticals, Inc.	$243M	$260,000 0.03% of portfolio	22,454	Q3 2024 New
TSVT 2seventy Bio, Inc.	$103M	$244,000 0.02% of portfolio	51,713	Q3 2024 New
ACAD Acadia Pharmaceuticals Inc	$3.17B	$203,000 0.02% of portfolio	13,218	Q3 2024 New
TRDA Entrada Therapeutics, Inc.	$439M	$202,000 0.02% of portfolio	12,638	Q3 2024 Added 0.8%
DSGN Design Therapeutics, Inc.	$270M	$194,000 0.02% of portfolio	36,099	Q3 2024 Added 33.07%
STOK Stoke Therapeutics, Inc.	$497M	$171,000 0.02% of portfolio	13,984	Q3 2024 Reduced 0.39%
ALDX Aldeyra Therapeutics, Inc.	$318M	$169,000 0.02% of portfolio	31,402	Q3 2024 New
ABCL Ab Cellera Biologics Inc.	$964M	$166,000 0.02% of portfolio	64,304	Q3 2024 Reduced 73.0%
ATXS Astria Therapeutics, Inc.	$115M	$140,000 0.01% of portfolio	12,749	Q3 2024 New
EDIT Editas Medicine, Inc.	$94.2M	$134,000 0.01% of portfolio	39,546	Q3 2024 Reduced 83.96%
VYGR Voyager Therapeutics, Inc.	$218M	$129,000 0.01% of portfolio	22,163	Q3 2024 Reduced 70.72%
RAPT Rapt Therapeutics, Inc.	$32.9M	$74,000 0.01% of portfolio	36,998	Q3 2024 Reduced 62.17%
SCPH Sc Pharmaceuticals Inc.	$88M	$69,000 0.01% of portfolio	15,164	Q3 2024 Reduced 12.6%
KOD Kodiak Sciences Inc.	$300M	$42,000 0.0% of portfolio	16,310	Q2 2024 New
PBYI Puma Biotechnology, Inc.	$128M	$28,000 0.0% of portfolio	11,131	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.